Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients.

Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients.

BACKGROUND: Cytomegalovirus infection in renal transplant recipients is a major clinical problem, with both short and long term sequelae. Infection can occur as a result of reactivation of latent virus or new infection from donor tissues. The impact of donor and recipient serostatus on viremia is w...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Hughes, D, Hafferty, J, Fulton, L, Friend, P, Devaney, A, Loke, J, Welsh, K, Handa, A, Klenerman, P
Natura:	Journal article
Lingua:	English
Pubblicazione:	2008

Documenti analoghi

How Do Donor-recipient CMV Serostatus and Post-hematopoietic Stem Cell Transplantation CMV Reactivation Affect Outcomes in Acute Leukemia Patients?
di: Mohammad Vaezi, et al.
Pubblicazione: (2016-10-01)

CMV infection of liver transplant recipients: comparison of antigenemia and molecular biology assays
di: Castro Ana, et al.
Pubblicazione: (2001-05-01)

Preemptive anti-cytomegalovirus therapy in high-risk (donor-positive, recipient-negative cytomegalovirus serostatus) kidney transplant recipients
di: Jumpei Hasegawa, et al.
Pubblicazione: (2017-12-01)

QuantiFERON CMV Test and CMV Serostatus in Lung Transplant: Stratification Risk for Infection, Chronic and Acute Allograft Rejection
di: Paolo Solidoro, et al.
Pubblicazione: (2024-08-01)

Low-dose valaciclovir prophylaxis against cytomegalovirus disease in renal transplant recipients.
di: Reddy, S, et al.
Pubblicazione: (2003)

Cytomegalovirus Serostatus and Functional Impairment in Liver Transplant Recipients in the Current Era
di: Nina Singh, et al.
Pubblicazione: (2021-08-01)

DETERMINAZIONE DI CMV-ANTIGENEMIA E DI CMV-DNA QUANTITATIVO: TRE ANNI DI ESPERIENZA.
di: A. Rossi, et al.
Pubblicazione: (2007-09-01)

MONITORING OF CMV INFECTION IN KIDNEY TRANSPLANT RECIPIENTS
di: Zhivka Stoykova, et al.
Pubblicazione: (2017-12-01)

Early renal function trajectories, cytomegalovirus serostatus and long-term graft outcomes in kidney transplant recipients
di: Jonathan P. Law, et al.
Pubblicazione: (2021-03-01)

Patient years lost due to cytomegalovirus serostatus mismatching in the scientific registry of transplant recipients
di: Maheen Z. Abidi, et al.
Pubblicazione: (2024-01-01)

Combined Analysis of Early CD4<sup>+</sup> T Cell Counts and CMV Serostatus May Improve CMV Risk Assessment after Allogeneic Hematopoietic Cell Transplantation
di: Saskia Leserer, et al.
Pubblicazione: (2021-11-01)

Anti-CMV serostatus correlates with shortened progression free- and overall survival in patients with glioblastoma
di: H. Krenzlin, et al.
Pubblicazione: (2021-01-01)

COMPARAZIONE DEI VALORI DI ANTIGENEMIA E VIREMIA DA CMV IN PAZIENTI TRAPIANTATI RENALI.
di: C. Di Natale, et al.
Pubblicazione: (2005-09-01)

IMPACT OF PRETRANSPLANT DONOR AND RECIPIENT CYTOMEGALOVIRUS SEROSTATUS ON OUTCOME FOR MULTIPLE MYELOMA PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION.
di: Jean Elcheikh
Pubblicazione: (2013-04-01)

DIAGNOSTICA PRECOCE DEL CMV: ANTIGENEMIA E DNA (PCR REAL TIME) A CONFRONTO
di: E. Mascheroni, et al.
Pubblicazione: (2005-09-01)

Prevention and management of CMV infection in pediatric solid organ transplant recipients
di: Shanthi S. Balani, et al.
Pubblicazione: (2023-02-01)

CMV-associated adrenal insufficiency in a renal transplant recipient
di: Nilesh Tejura, et al.
Pubblicazione: (2018-01-01)

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.
di: Hyeyoung Lee, et al.
Pubblicazione: (2017-01-01)

Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients.
di: Jong Man Kim, et al.
Pubblicazione: (2015-01-01)

“Mini” bank of only 8 donors supplies CMV-directed T cells to diverse recipients
di: Ifigeneia Tzannou, et al.
Pubblicazione: (2019-09-01)

Utility of CMV-Specific Immune Monitoring for the Management of CMV in Solid Organ Transplant Recipients: A Clinical Update
di: Katya Prakash, et al.
Pubblicazione: (2021-05-01)

CMV specific T cell immune response in hepatitis C negative kidney transplant recipients receiving transplant from hepatitis C viremic donors and hepatitis C aviremic donors
di: Ambreen Azhar, et al.
Pubblicazione: (2022-12-01)

Long-term CMV monitoring and chronic rejection in renal transplant recipients
di: Shoko Ishikawa, et al.
Pubblicazione: (2023-06-01)

COMPARAÇÃO ENTRE TÉCNICAS DE IMUNOISTOQUÍMICA E DE IMUNOFLUORESCÊNCIA PARA ANTIGENEMIA PP65 DO CITOMEGALOVÍRUS (CMV) EM RECEPTORES DE TRANSPLANTE
di: Regina Barbosa Schroeder, et al.
Pubblicazione: (2009-03-01)

Factors influencing CMV seropositivity in stem cell transplant patients and donors
di: Per Ljungman, et al.
Pubblicazione: (2007-08-01)

CMV Infection and Lymphopenia: Warning Markers of Pneumocystis Pneumonia in Kidney Transplant Recipients
di: Isabelle Eberl, et al.
Pubblicazione: (2024-01-01)

Association of the Co-stimulatory Molecules Polymorphisms with CMV Infection in Liver Transplant Recipients
di: M. H. Karimi, et al.
Pubblicazione: (2011-10-01)

Bridging the gap: assessing CMV DNAemia in kidney transplant recipients with previous solid organ transplants
di: Goni Katz-Greenberg, et al.
Pubblicazione: (2024-04-01)

Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV‐specific T cells
di: Helen M McGuire, et al.
Pubblicazione: (2020-01-01)

A Systematic Review and Meta-analysis of Optimized CMV Preemptive Therapy and Antiviral Prophylaxis for CMV Disease Prevention in CMV High-Risk (D+R-) Kidney Transplant Recipients
di: Lakshin Kumar, et al.
Pubblicazione: (2023-08-01)

INFEZIONE DA CYTOMEGALOVIRUS (CMV): UN CONFRONTO TRA ANTIGENEMIA E UN TEST QUANTITATIVO IN REAL TIME PCR
di: C. Giraldi, et al.
Pubblicazione: (2007-09-01)

Evaluation of the XM-ONE assay and the role of endothelial cell antibodies in recipients of living donor renal transplants
di: Procter, J, et al.
Pubblicazione: (2009)

CMV and the art of memory maintenance.
di: Klenerman, P, et al.
Pubblicazione: (2008)

Impact of CMV PCR Blips in Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation
di: Isabelle P. Lodding, MD, et al.
Pubblicazione: (2018-06-01)

Acute and Chronic Changes in Gene Expression After CMV DNAemia in Kidney Transplant Recipients
di: Richard Ahn, et al.
Pubblicazione: (2021-11-01)

CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART.
di: Isabelle Poizot-Martin, et al.
Pubblicazione: (2016-01-01)

Evaluation of the XM-ONE (R) assay and the role of endothelial cell antibodies in recipients of living donor renal transplants
di: Procter, J, et al.
Pubblicazione: (2009)

Complement and renal transplantation: from donor to recipient.
di: Damman, J, et al.
Pubblicazione: (2008)

Treatment of Cytomegalovirus Infection with Cidofovir and CMV Immune Globulin in a Lung Transplant Recipient
di: Heinrike Wilkens, et al.
Pubblicazione: (2016-01-01)

Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant Recipients
di: Smaranda Gliga, et al.
Pubblicazione: (2021-01-01)